France Healthcare Equipment & Supplies

Affluent Medical SAS (AFME)

Track

Affluent Medical SAS recorded its most recent insider activity on February 2, 2026. Truffle Capital SAS, represented by Philippe Pouletty, executed a significant purchase of 2,136,751 shares. This transaction follows a series of consistent acquisitions by the same entity over previous years, reflecting long-term accumulation patterns within the firm's equity structure.
Ticker: AFME Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Affluent Medical SAS. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 2 Feb 2026
Value €2,333,679.57 | Price 23.52 | Shares 24,428
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02 B Purchase TRUFFLE CAPITAL SAS

Philippe POULETTY, Directeur Général Truffle Capital

Officer
24,428
23.52
€2,333,680 		24,428 23.52 €2,333,680
2025-10-21 2025-10-20 B Purchase TRUFFLE CAPITAL SAS

Philippe POULETTY, Directeur Général Truffle Capital

Officer
18,025
231.24
€3,814,847 		18,025 231.24 €3,814,847
2025-09-24 2025-07-21 B Purchase TRUFFLE CAPITAL SAS

Philippe POULETTY, Directeur Général Truffle Capital

Officer
21,184
82.18
€2,248,243 		21,184 82.18 €2,248,243
2024-02-05 2024-01-29 B Purchase TRUFFLE CAPITAL SAS

Philippe Pouletty, Membre du conseil d'administration

Director
1,419,871
1.56
€2,214,999 		1,419,871 1.56 €2,214,999
2023-03-28 2023-03-06 B Purchase
1.0
Sebastien Ladet

Directeur general

Officer
14,820
0.03
€445 		14,820 0.03 €445
2023-03-28 2023-03-06 B Purchase
1.0
Sebastien Ladet

Directeur general

Officer
14,820
1.32
€19,562 		14,820 1.32 €19,562
2023-03-09 2023-03-06 B Purchase TRUFFLE CAPITAL SAS

Philippe Pouletty, Membre du conseil d'administration

Director
6,363,034
1.32
€8,399,205 		6,363,034 1.32 €8,399,205
2023-03-09 2023-03-06 B Purchase TRUFFLE CAPITAL SAS

Philippe Pouletty, Membre du conseil d'administration

Director
6,363,034
0.03
€190,891 		6,363,034 0.03 €190,891
2022-09-22 2022-09-22 B Purchase TRUFFLE CAPITAL SAS SAS

Philippe Pouletty, Membre du conseil d'administration

Director
1,637,931
2.32
€3,800,000 		1,637,931 2.32 €3,800,000
2022-09-13 2022-09-09 S Sale HOLDING INCUBATRICE SERIE II Société anonyme

Membre du Conseil d'Administration

Director
275,000
0.04
€11,000 		275,000 0.04 €11,000
Explore more

More insider trading research around Affluent Medical SAS

More insider trades in France
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe